Shiga toxin-producing Escherichia coli O157 associated with human infections in Switzerland, 2000-2009

Epidemiology and Infection

Volumn 139, Issue 7, 2011, Pages 1097-1104

  Kappeli U ^a   Hachler H ^a   Giezendanner, N ^a   Cheasty, T ^b   Stephan, R ^a  

^a UNIVERSITY OF ZURICH   (Switzerland)

^b PUBLIC HEALTH ENGLAND   (United Kingdom)

Author keywords

Characteristics; epidemiology; human infection; STEC O157

Indexed keywords

ANTIBIOTIC RESISTANCE; ANTIBIOTIC SENSITIVITY; ARTICLE; BACTERIAL GENE; BACTERIAL STRAIN; BACTERIOPHAGE TYPING; BACTERIUM ISOLATION; BLOODY DIARRHEA; CONTROLLED STUDY; EAE GENE; EHXA GENE; ESCHERICHIA COLI INFECTION; ESCHERICHIA COLI O157; GENETIC VARIABILITY; HEMOLYTIC UREMIC SYNDROME; HUMAN; MEDICAL HISTORY; NONHUMAN; SHIGA TOXIN PRODUCING ESCHERICHIA COLI; STX2 GENE; STX2C GENE; SWITZERLAND;

EID: 85027943106     PISSN: 09502688     EISSN: 14694409     Source Type: Journal    
DOI: 10.1017/S0950268810002190     Document Type: Article

References (33)

1. Hedican EB, et al. Characteristics of O157 versus non-O157 shiga toxin-producing Escherichia coli infections in Minnesota, 2000-2006. Clinical Infectious Disease 2009; 49: 358-364.
2. Werber D, et al. Shiga toxin-producing Escherichia coli serogroups in food and patients, Germany. Emerging Infectious Disease 2008; 14: 1803-1806.
3. Blanco JE, et al. Serotypes, virulence genes, and intimin types of shiga toxin (verotoxin)-producing Escherichia coli isolates from human patients : prevalence in Lugo, Spain, from 1992 through 1999. Journal of Clinical Microbiology 2004; 42: 311-319.
4. Feng PC, et al. Genetic diversity among clonal lineages within Escherichia coli O157:H7 stepwise evolutionary model. Emerging Infectious Disease 2007; 13: 1701-1706. (Pubitemid 350126198)
5. Bielaszewska M, et al. Isolation and characterization of sorbitol-fermenting shiga toxin (verocytotoxin)-producing Escherichia coli O157:H- strains in the Czech Republic. Journal of Clinical Microbiology 1998;36: 2135-2137. (Pubitemid 28277824)
6. Friedrich AW, et al. Prevalence, virulence profiles, and clinical significance of shiga toxin-negative variants of enterohemorrhagic Escherichia coli O157 infection in humans. Clinical Infectious Disease 2007; 45: 39-45. (Pubitemid 46984613)
7. Bielaszewska M, et al. Shiga toxin-negative attaching and effacing Escherichia coli : distinct clinical associations with bacterial phylogeny and virulence traits and inferred in-host pathogen evolution. Clinical Infectious Disease 2008; 47: 208-217. (Pubitemid 351920622)
8. Zweifel C, Stephan R. Microbiological monitoring of sheep carcass contamination in three Swiss abattoirs. Journal of Food Protection 2003; 66: 946-952. (Pubitemid 36689324)
9. Abdulmawjood A, Roth S, Bulte M. Two methods for construction of internal amplification controls for the detection of Escherichia coli O157 by polymerase chain reaction. Molecular and Cellular Probes 2002; 16:335-339. (Pubitemid 35397436)
10. Gannon VP, et al. Use of the flagellar H7 gene as a target in multiplex PCR assays and improved specificity in identification of enterohemorrhagic Escherichia coli strains. Journal of Clinical Microbiology 1997; 35:656-662. (Pubitemid 27083856)
11. Russmann H, et al. Genotyping of shiga-like toxin genes in non-O157 Escherichia coli strains associated with haemolytic uraemic syndrome. Journal of Medical Microbiology 1995; 42: 404-410.
12. Blanco M, et al. Serotypes, virulence genes, and intimin types of shiga toxin (verotoxin)-producing Escherichia coli isolates from healthy sheep in Spain. Journal of Clinical Microbiology 2003; 41: 1351-1356. (Pubitemid 36428072)
13. Schmidt H, Beutin L, Karch H. Molecular analysis of the plasmid-encoded hemolysin of Escherichia coli O157:H7 strain EDL 933. Infection and Immunity 1995; 63: 1055-1061.
14. Stephan R, Hoelzle LE. Characterization of shiga toxin type 2 variant B-subunit in E. coli strains from asymptomatic human carriers by PCR-RFLP. Letters in Applied Microbiology 2000; 31: 139-142. (Pubitemid 30658997)
15. Khakhria R, Duck D, Lior H. Extended phage-typing scheme for Escherichia coli O157:H7. Epidemiology and Infection 1990; 105: 511-520.
16. Wirth T, et al. Sex and virulence in Escherichia coli: an evolutionary perspective. Molecular Microbiology 2006; 60: 1136-1151.
17. Ammon A, Petersen LR, Karch H. A large outbreak of hemolytic uremic syndrome caused by an unusual sorbitol-fermenting strain of Escherichia coli O157:H-. Journal of Infectious Diseases 1999; 179: 1274-1277. (Pubitemid 29196514)
18. Gould LH, et al. Hemolytic uremic syndrome and death in persons with Escherichia coli O157:H7 infection, foodborne diseases active surveillance network sites, 2000-2006. Clinical Infectious Disease 2009; 49:1480-1485.
19. Chalmers RM, et al. The surveillance of vero cytotoxin-producing Escherichia coli O157 in Wales, 1990 to 1998. Emerging Infectious Disease 1999; 5: 566-569.
20. Willshaw GA, et al. Verocytotoxin-producing Escherichia coli (VTEC) O157 and other VTEC from human infections in England and Wales: 1995-1998. Journal of Medical Microbiology 2001; 50: 135-142.
21. Orth D, Wurzner R. What makes an enterohemorrhagic Escherichia coli ? Clinical Infectious Disease 2006; 43: 1168-1169.
22. Mora A, et al. Antimicrobial resistance of shiga toxin (verotoxin)-producing Escherichia coli O157:H7 and non-O157 strains isolated from humans, cattle, sheep and food in Spain. Research in Microbiology 2005; 156:793-806.
23. Beutin L, et al. Characterization of shiga toxinproducing Escherichia coli strains isolated from human patients in Germany over a 3-year period. Journal of Clinical Microbiology 2004; 42: 1099-1108. (Pubitemid 38332832)
24. Karch H, et al. Verocytotoxin-producing Escherichiacoli causing a hemolytic-uremic syndrome in children. Deutsche Medizinische Wochenschrift 1990; 115: 489-495. (Pubitemid 20107728)
25. Monday SR, Minnich SA, Feng PC. A 12-base-pair deletion in the flagellar master control gene fliC causes nonmotility of the pathogenic German sorbitol-fermenting Escherichia coli O157:H- strains. Journal of Bacteriology 2004; 186: 2319-2327. (Pubitemid 38451835)
26. Karch H, Tarr PI, Bielaszewska M. Enterohaemorrhagic Escherichia coli in human medicine. International Journal of Medical Microbiology 2005; 295:405-418. (Pubitemid 41225453)
27. Karch H, Bielaszewska M. Sorbitol-fermenting shiga toxin-producing Escherichia coli O157:H(-) strains : epidemiology, phenotypic and molecular characteristics, and microbiological diagnosis. Journal of Clinical Microbiology 2001; 39: 2043-2049. (Pubitemid 32531456)
28. Thomas A, et al. Vero cytotoxin-producing Escherichia coli, particularly serogroup O157, associated with human infections in England and Wales: 1992-1994. Epidemiology and Infection 1996; 117: 1-10.
29. - causes another outbreak of haemolytic uraemic syndrome in children. Epidemiology and Infection 2009; 137: 389-395.
30. Conedera G, et al. A family outbreak of Escherichia coli O157 haemorrhagic colitis caused by pork meat salami. Epidemiology and Infection 2007; 135: 311-314. (Pubitemid 46322070)
31. King L, et al. Community-wide outbreak of Escherichia coli O157:H7 associated with consumption of frozen beef burgers. Epidemiology and Infection 2009; 137: 889-896.
32. Schmidt H, et al. Antibiotic susceptibilities of verocytotoxin-producing Escherichia coli O157 and non-O157 strains isolated from patients and healthy subjects in Germany during 1996. Journal of Antimicrobial Chemotherapy 1998; 42: 548-550. (Pubitemid 28473021)
33. - from different origins. Microbial Drug Resistance 2007; 13: 44-51.